Flutibact Ointment is a topical medication combining Fluticasone Propionate (0.005% w/w), a potent corticosteroid, with Mupirocin (2% w/w), a bactericidal antibiotic, designed to treat inflammatory skin conditions complicated by bacterial infections. Fluticasone Propionate works by reducing inflammation, redness, and itching through its anti-inflammatory, antipruritic, and vasoconstrictive properties, while Mupirocin targets and inhibits bacterial protein synthesis, effectively eliminating susceptible Gram-positive bacteria, including Staphylococcus aureus and Streptococcus species. This dual-action formulation is particularly useful in managing infected eczema, dermatitis, impetigo, and other superficial skin infections where inflammation and bacterial colonization coexist. The ointment should be applied topically to the affected area in a thin layer, typically two to three times daily, as directed by a healthcare professional. It is intended for short-term use to minimize potential side effects associated with corticosteroids, such as skin thinning or systemic absorption. Flutibact Ointment is contraindicated in viral, fungal, or tuberculosis skin infections and should be used cautiously in patients with hypersensitivity to any of its components. Proper hygiene and adherence to prescribed duration enhance treatment efficacy and reduce the risk of resistance development.